Ex­clu­sive: As­traZeneca and Vaxess de­vel­op­ing skin patch mR­NA vac­cines for pan­dem­ic flu

Last year
Deals
R&D

Rap­port bags $150M Se­ries B just five months af­ter nine-fig­ure launch for epilep­sy, psy­chi­a­try tri­als

Last year
Financing
Startups

Apel­lis' safe­ty probe in­to eye drug un­earths is­sues with in­jec­tion kits, while side ef­fects re­main 'very rare'

Last year
R&D
Pharma

Re­searchers sug­gest new meth­ods to fi­nance pe­di­atric can­cer R&D — Na­ture pa­per

Last year
Pharma

Boehringer In­gel­heim files suit to block drug price ne­go­ti­a­tions. Is the fight ul­ti­mate­ly head­ed for the Supreme ...

Last year
Pharma

Gov­ern­ment pan­el of­fers strongest rec­om­men­da­tion for PrEP to pre­vent HIV

Last year
Pharma

FDA warns Ama­zon and Wal­mart over sale of un­ap­proved prod­uct

Last year
Pharma
FDA+

UK in­vests $13M+ in 17 bio­phar­ma man­u­fac­tur­ers

Last year
Pharma
Manufacturing

Op­er­a­tion Warp Speed re­dux: HHS awards $1.4B to de­vel­op next-gen Covid-19 drugs and vac­cines

Last year
Pharma
FDA+

Bay­er's new busi­ness unit teams up with Ma­hana Ther­a­peu­tics to com­mer­cial­ize dig­i­tal treat­ments

Last year
Pharma

CMS lays out how se­niors can pay for drugs on a month­ly ba­sis in 2025 and be­yond

Last year
Pharma
FDA+

EMA blocks drug pro­duc­tion at Ser­ra Pamies' Span­ish fa­cil­i­ty due to man­u­fac­tur­ing, man­age­ment is­sues

Last year
Manufacturing

Hori­zon, Roche top list for phar­ma rep­u­ta­tion among rare dis­ease pa­tient groups, sur­vey finds

Last year
Pharma
Marketing

No­vavax says up­dat­ed Covid-19 jab works against two sub­vari­ants; Ul­ti­movacs re­vis­es PhII can­cer vac­cine read­out

Last year
News Briefing

Ful­crum’s sick­le cell hold re­solved, and tri­al will now fo­cus on more se­vere pa­tients

Last year
R&D
FDA+

La­va Ther­a­peu­tics makes cuts to its head­count

Last year
People
R&D

Mar­ket­ingRx roundup: Alzheimer’s As­so­ci­a­tion rais­es aware­ness in His­pan­ic com­mu­ni­ty; Can­cer re­search fundrais­er ...

Last year
Pharma
Marketing

In­ovio spin­out plans piv­otal study for can­cer vac­cine as it touts al­ter­na­tive take on PhIb/IIa liv­er can­cer da­ta

Last year
R&D

In­ver­sa­go was work­ing to­ward a po­ten­tial 2024 IPO, but No­vo’s in­ter­est won out. CB1 biotechs hope to ride the wave

Last year
Deals
Pharma

Ar­a­vive warns of pos­si­ble liq­ui­da­tion as it ax­es all clin­i­cal work, lays off 70% of em­ploy­ees

Last year
People
R&D

Te­va agrees to pay $225M in fines to set­tle DOJ charges of price-fix­ing gener­ic drugs

Last year
Pharma

Pfiz­er's ma­ter­nal RSV vac­cine ap­proved to help pro­tect new­borns

Last year
Pharma
FDA+

Spring­Works fix­es 'mi­nor da­ta han­dling er­ror' af­ter March Form 483 for tri­al site linked to up­com­ing PDU­FA

Last year
FDA+

US Patent and Trade­mark Of­fice to hear patent chal­lenge over ex­per­i­men­tal seizure treat­ment

Last year
Pharma
Law
First page Previous page 292293294295296297298 Next page Last page
A service from the Financial Times